Evidence map›Paper›PMID 26402096›Full record

ArticleJournal of Alzheimer's disease : JAD2015

Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.

Shelby Meier, Michelle Bell, Danielle N Lyons, Alexandria Ingram, Jing Chen, John C Gensel, Haining Zhu, Peter T Nelson, Jose F Abisambra

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. ThebioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Progressive Supranuclear Palsy PERK Haplotype B Selectively Translates DLX1 Promoting Tau Toxicity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shelby MeierSanders Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Michelle BellSanders Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Danielle N LyonsSanders Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Alexandria IngramSanders Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Jing ChenDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.
John C GenselSpinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY, USA.
Haining ZhuDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.
Peter T NelsonSanders Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Jose F AbisambraSanders Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
University of Kentucky · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI SCHMITT, FREDERICK · 2006 to 2020
$23.3M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
UK Spinal Cord &Brain Injury Research Center Core GrantP30NS051220 · NINDS · UNIVERSITY OF KENTUCKY · PI HALL, EDWARD D. · 2005 to 2015
$6.4M
Center for Biomedical Research Excellence in the Molecular Basis of Human DiseaseP20GM103486 · NIGMS · UNIVERSITY OF KENTUCKY · PI LOUIS HERSH, LOUIS HERSH LOUIS HERSH · 2012 to 2013
$4.2M
Role of FUS in ALSR01NS077284 · NINDS · UNIVERSITY OF KENTUCKY · PI ZHU, HAINING · 2011 to 2014
$1.3M
LTQ Orbitrap XL ETD mass spectrometerS10RR029127 · NCRR · UNIVERSITY OF KENTUCKY · PI ZHU, HAINING · 2010 to 2010
$908k
NCATS NIH HHS 5UL1TR000117-04NCATS NIH HHS UL1 TR000117NCI NIH HHS P30 CA177558NCI NIH HHS P30CA177558NCRR NIH HHS S10 RR029127NCRR NIH HHS S10RR029127NIA NIH HHS P30 AG028383NIGMS NIH HHS P20 GM103486NIGMS NIH HHS P20GM103486NIMHD NIH HHS L32 MD009205NINDS NIH HHS P30 NS051220NINDS NIH HHS P30NS051220NINDS NIH HHS R01 NS077284NINDS NIH HHS R01NS077284
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is pathologically characterized by the formation of extracellular amyloid plaques and intraneuronal tau tangles. We recently identified that tau associates with proteins known to participate in endoplasmic reticulum (ER)-associated degradation (ERAD); consequently, ERAD becomes dysfunctional and causes neurotoxicity. We hypothesized that tau associates with other ER proteins, and that this association could also lead to cellular dysfunction in AD. Portions of human AD and non-demented age matched control brains were fractionated to obtain microsomes, from which tau was co-immunoprecipitated. Samples from both conditions containing tau and its associated proteins were analyzed by mass spectrometry. In total, we identified 91 ER proteins that co-immunoprecipitated with tau; 15.4% were common between AD and control brains, and 42.9% only in the AD samples. The remainder, 41.8% of the proteins, was only seen in the control brain samples. We identified a variety of previously unreported interactions between tau and ER proteins. These proteins participate in over sixteen functional categories, the most abundant being involved in RNA translation. We then determined that association of tau with these ER proteins was different between the AD and control samples. We found that tau associated equally with the ribosomal protein L28 but more robustly with the ribosomal protein P0. These data suggest that the differential association between tau and ER proteins in disease could reveal the pathogenic processes by which tau induces cellular dysfunction.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseBlotting, WesternEndoplasmic ReticulumFemaleFluorescent Antibody TechniqueHumansImmunoprecipitationMaleMass SpectrometryMicroscopy, ConfocalMicrosomesProteometau ProteinsTemporal LobeMAPT protein, humanProteometau ProteinsAlzheimer’s diseaseco-immunoprecipitationendoplasmic reticulummass spectrometrymicrosomeribosometautauopathies

Identifiers

PMID26402096
PMCPMC4881838
OpenAlexW2207904128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.